[{"indications": "Indications\u00a0overdosage with opioids; reversal of postoperative\r\nrespiratory depression and reversal of neonatal respiratory and CNS\r\ndepression resulting from opioid administration to mother during labour\r\n(section 15.1.7)", "name": "NALOXONE HYDROCHLORIDE - ANALGESICS (OPIOID)", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "Emergency treatment of poisoning", "Specific drugs", "Analgesics (opioid)"], "cautions": "Cautions\u00a0physical dependence on opioids; cardiac irritability; naloxone is short-acting, \n(From Analgesics (opioid): British National Formulary)\nAnalgesics (opioid)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/29533.htm", "doses": ["By intravenous injection, 0.4\u20132\u00a0mg;\r\nif no response, repeat at intervals of 2\u20133 minutes to a max. of 10\u00a0mg\r\n(then review diagnosis); further doses may be required if respiratory\r\nfunction deteriorates; child 10\u00a0micrograms/kg;\r\nif no response, give subsequent dose of 100\u00a0micrograms/kg (then review\r\ndiagnosis); further doses may be required if respiratory function\r\ndeteriorates", "By subcutaneous or intramuscular injection, adult and child dose as for intravenous\r\ninjection but use only if intravenous route not feasible (onset of\r\naction slower)", "By continuous intravenous infusion using an infusion pump, adult and child, rate adjusted according to response (initially,\r\nrate may be set at 60% of the initial resuscitative intravenous\r\ninjection dose per hour)", "The initial resuscitative intravenous\r\ninjection dose is that which maintained satisfactory ventilation\r\nfor at least 15 minutes", "Doses used in acute opioid overdosage\r\nmay not be appropriate for the management of opioid-induced respiratory\r\ndepression and sedation in those receiving palliative care and in\r\nchronic opioid use; see also section 15.1.7 for management\r\nof postoperative respiratory depression"], "pregnancy": "Pregnancy\u00a0section 15.1.7"}, {"indications": "Indications\u00a0see under Dose", "name": "NALOXONE HYDROCHLORIDE - ANTAGONISTS FOR CENTRAL AND RESPIRATORY DEPRESSION", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "15 Anaesthesia", "15.1 General anaesthesia", "15.1.7 Antagonists for central and respiratory depression"], "cautions": "Cautions\u00a0cardiovascular disease or\r\nthose receiving cardiotoxic drugs (serious adverse cardiovascular\r\neffects reported); physical dependence\r\non opioids (precipitates withdrawal); pain (see also under Titration of Dose, below); has short\r\nduration of action (repeated doses or infusion may be necessary to\r\nreverse effects of opioids with longer duration of action)Titration of dose\u00a0In postoperative\r\nuse, the dose should be titrated for each patient in order to obtain\r\nsufficient respiratory response; however, naloxone antagonises analgesia", "side-effects": "Side-effects\u00a0nausea, vomiting; hypotension, hypertension, ventricular\r\ntachycardia and fibrillation, cardiac arrest; hyperventilation, dyspnoea,\r\npulmonary oedema; headache, dizziness; less commonly diarrhoea, dry mouth, agitation, excitement, paraesthesia, tremor,\r\nsweating; very rarely seizures, erythema multiforme,\r\nand hypersensitivity reactions including anaphylaxis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/6677.htm", "doses": ["Reversal of postoperative respiratory depression, adult and child over\r\n12 years, by intravenous injection, 100\u2013200\u00a0micrograms\r\n(1.5\u20133\u00a0micrograms/kg); if response inadequate, give subsequent dose\r\nof 100\u00a0micrograms every 2 minutes; alternatively, subsequent doses\r\ncan be given by intramuscular injection every 1\u20132 hours; child 1 month\u201312 years see BNF for Children", "Reversal of respiratory and CNS depression resulting from opioid\r\nadministration to mother during labour, neonate, by intramuscular injection, 200\u00a0micrograms (60\u00a0micrograms/kg)\r\nas a single dose at birth; alternatively by subcutaneous or intravenous injection, 10\u00a0micrograms/kg,\r\nrepeated every 2\u20133 minutes", "Opioid overdose, see Emergency Treatment of Poisoning", "Naloxone doses in BNF may differ from those\r\nin product literature"], "pregnancy": "Pregnancy\u00a0use only if potential benefit outweighs risk"}, {"indications": "Indications\u00a0overdosage with opioids; reversal of postoperative\r\nrespiratory depression and reversal of neonatal respiratory and CNS\r\ndepression resulting from opioid administration to mother during labour\r\n(section 15.1.7)", "name": "NALOXONE HYDROCHLORIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "Emergency treatment of poisoning", "Specific drugs", "Analgesics (opioid)"], "cautions": "Cautions\u00a0physical dependence on opioids; cardiac irritability; naloxone is short-acting, \n(From Analgesics (opioid): British National Formulary)\nAnalgesics (opioid)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/29533.htm", "doses": ["By intravenous injection, 0.4\u20132\u00a0mg;\r\nif no response, repeat at intervals of 2\u20133 minutes to a max. of 10\u00a0mg\r\n(then review diagnosis); further doses may be required if respiratory\r\nfunction deteriorates; child 10\u00a0micrograms/kg;\r\nif no response, give subsequent dose of 100\u00a0micrograms/kg (then review\r\ndiagnosis); further doses may be required if respiratory function\r\ndeteriorates", "By subcutaneous or intramuscular injection, adult and child dose as for intravenous\r\ninjection but use only if intravenous route not feasible (onset of\r\naction slower)", "By continuous intravenous infusion using an infusion pump, adult and child, rate adjusted according to response (initially,\r\nrate may be set at 60% of the initial resuscitative intravenous\r\ninjection dose per hour)", "The initial resuscitative intravenous\r\ninjection dose is that which maintained satisfactory ventilation\r\nfor at least 15 minutes", "Doses used in acute opioid overdosage\r\nmay not be appropriate for the management of opioid-induced respiratory\r\ndepression and sedation in those receiving palliative care and in\r\nchronic opioid use; see also section 15.1.7 for management\r\nof postoperative respiratory depression"], "pregnancy": "Pregnancy\u00a0section 15.1.7"}]